China · Delayed Price · Currency is CNY Beijing Bohui Innovation Biotechnology Group Company Description
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China.
The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies.
It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay Analyzers, and Quantum Dot Analyzer; and detection kits for respiratory, intestinal, reproductive infections, as well as trace element testing, allergen testing, and others.
In addition, the company offers mass spectrometers, plate readers, and standardized ion sources; and flash, process, and preparative purification systems.
The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.
| Country | China |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,179 |
| CEO | Zhiwei Shen |
Contact Details
Address: No. 9, Shengshengyuan Road Beijing, 102206 China | |
| Phone | 86 10 8885 0168 |
| Website | bohui-tech.com |
Stock Details
| Ticker Symbol | 300318 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001QR4 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Zhiwei Shen | Chairman of the Board and GM |
| Jia Liu | Financial Director |
| Haifeng Dong | Deputy GM, Secretary and Director |
| Wei Na Gong | Accounting Supervisor |